Fingerprint
Dive into the research topics where Steven I Sherman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Characterization of Advanced RAS-driven Follicular-derived Thyroid Cancers and Review of Future Therapeutic Avenues
Hamidi, S., Maniakas, A., Akhave, N. S., Banuchi, V. E., Busaidy, N. L., Dadu, R., Ferrarotto, R., Guise, T. A., Hofmann, M. C., Hosseini, S. M., Hu, M. I., Iyer, P. C., Mansour, M., Marczyk, V. R., Roy-Chowdhuri, S., Sherman, S. I., Sousa, L. G., Wang, J. R., Williams, M. D. & Zafereo, M. E. & 2 others, , Feb 1 2026, In: Journal of Clinical Endocrinology and Metabolism. 111, 2, p. 471-483 13 p.Research output: Contribution to journal › Review article › peer-review
-
Definitive Radiotherapy for Oligometastatic and Oligoprogressive Thyroid Cancer: A Potential Strategy for Systemic Therapy Deferral
Dudzinski, S. O., Cabanillas, M. E., Hamidi, S., Marczyk, V. R., Busaidy, N. L., Dadu, R., Welsh, J., Hu, M. I., Gunn, B., Wang, C., Waguespack, S. G., Phan, J., Beckham, T. H., Chang, J. Y., Sherman, S. I., Reddy, J. P., Ying, A. K., O’Reilly, M. S., Chen, A. & Lee, A. & 7 others, , Jan 2025, In: JNCCN Journal of the National Comprehensive Cancer Network. 23, 1, e247072.Research output: Contribution to journal › Article › peer-review
3 Link opens in a new tab Scopus citations -
Efficacy and Safety of Selective RET Inhibitors in Patients with Advanced Hereditary Medullary Thyroid Carcinoma
Hamidi, S., Yedururi, S., Hu, M. I., Busaidy, N. L., Sherman, S. I., Jimenez, C., Grubbs, E. G., Maniakas, A., Zafereo, M. E., Subbiah, V. & Waguespack, S. G., Jan 1 2025, In: Thyroid. 35, 1, p. 6-17 12 p.Research output: Contribution to journal › Article › peer-review
4 Link opens in a new tab Scopus citations -
Erratum: NTRK Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy (JCO Precision Oncology (2025) DOI: 10.1200/PO.24.00321)
Marczyk, V. R., Fazeli, S., Dadu, R., Busaidy, N. L., Iyer, P., Hu, M. I., Sherman, S. I., Hamidi, S., Hosseini, S. M., Williams, M. D., Ahmed, S., Routbort, M. J., Luthra, R., Roy-Chowdhuri, S., San Lucas, F. A., Patel, K. P., Hong, D. S., Zafereo, M., Wang, J. R. & Maniakas, A. & 2 others, , Jul 1 2025, In: JCO Precision Oncology. 9, e2500552.Research output: Contribution to journal › Comment/debate › peer-review
1 Link opens in a new tab Scopus citations -
Increasing Access and Quality Care for Immune Checkpoint Inhibitor–Related Thyroid Dysfunction
Brinkman, A. K., Salami-Henry, A. Y., Aaron-Brija, L. A., Hannah, F. M., Hu, M. I., Hwang, L. L., Patel, R. P., Rollins, J. L., Sherman, S. I., Williams, J. K., Kikani, N. J. & Weitzman, S. P., Dec 2025, In: JCO Oncology Practice. 19Research output: Contribution to journal › Article › peer-review